Phosphodiesterase inhibitors for the management of lower urinary tract symptoms in men without benign prostatic hyperplasia: a systematic review. [PDF]
Bakhsh A +12 more
europepmc +1 more source
Demonstration of a Heat-Stable Cyclic GMP Phosphodiesterase in the Medium of Physarum flavicomum [PDF]
Lynch, Thomas J., Ross, Mark S.
core +2 more sources
Beyond Isotretinoin: A Narrative Review of Emerging Systemic Therapies for Moderate-to-Severe Acne. [PDF]
Tommasino N +3 more
europepmc +1 more source
Exploring Patient Pathways and Care Situations in Men With Erectile Dysfunction in Different PDE-5 Inhibitor Regulatory Settings. [PDF]
May U, Werthner Q, Weigmann H, Bauer C.
europepmc +1 more source
Associations between phosphodiesterase type 5 inhibitors and vascular function: a systematic review and meta-analysis on randomized-controlled trials. [PDF]
Zhang Y +11 more
europepmc +1 more source
Exercise Attenuates Aortic Dissection Via PDE5A-Mediated Inhibition of Vascular Smooth Muscle Cell Phenotypic Switch. [PDF]
Zhang Y +11 more
europepmc +1 more source
Exploration of the Role of Cilostazol in Brugada Syndrome: Mechanisms, Therapeutic Potential, and Implications in the Prevention of Ventricular Arrhythmias. [PDF]
Iqbal M, Putra ICS, Karwiky G, Achmad C.
europepmc +1 more source
Excitability changes induced in rat neo-cortical neurons by the selective blockade of a low KM, Ca2+/calmodulin-independent cAMP-phosphodiesterase. [PDF]
B Sutor +5 more
core +1 more source
The c-di-AMP binding protein NadD from Mesomycoplasma ovipneumoniae functions as a phosphodiesterase that inhibits host inflammatory responses. [PDF]
Zhang Y, Xu Z, Li M, Hao X.
europepmc +1 more source
Phosphodiesterase-4 inhibition in localized scleroderma: A case series of topical roflumilast. [PDF]
Barnawi G +4 more
europepmc +1 more source

